# FOXR2

## Overview
FOXR2, or forkhead box R2, is a gene that encodes a transcription factor belonging to the forkhead box family, which is characterized by a distinct DNA-binding domain. The protein product, forkhead box R2, is primarily involved in the regulation of gene expression, playing a crucial role in cellular processes such as differentiation, proliferation, and development. As a transcription factor, forkhead box R2 operates within the nucleus, where it binds to specific DNA sequences to modulate the transcription of target genes. This regulatory function is essential for maintaining cellular homeostasis and ensuring proper organismal development. FOXR2 has garnered significant attention in the field of oncology due to its role as an oncogene, with overexpression linked to various cancers, including breast, lung, liver, and brain cancers (Gharbaran2023Insights; Li2016FOXR2). The gene's involvement in cancer progression and its interactions with other oncogenic proteins, such as MYC, underscore its potential as a target for therapeutic interventions (Tsai2022FOXR2).

## Function
FOXR2 (forkhead box R2) is a transcription factor that plays a significant role in regulating gene expression within healthy human cells. As a member of the forkhead box family, FOXR2 is primarily active in the nucleus, where it binds to DNA to modulate the transcription of target genes. This activity is crucial for various cellular processes, including cell differentiation, proliferation, and development. By influencing the expression of specific genes, FOXR2 contributes to the proper functioning and maintenance of cellular activities, ensuring that cells develop and proliferate correctly.

The molecular processes involving FOXR2 are essential for maintaining cellular homeostasis and facilitating normal organismal development. Its role in cell biology is underscored by its involvement in the regulation of genes that control cell cycle progression and differentiation pathways. The precise modulation of these pathways by FOXR2 ensures that cells can respond appropriately to developmental cues and environmental signals, which is vital for the overall health and development of the organism. The activity of FOXR2 in the nucleus highlights its importance in the transcriptional regulation of genes that are critical for cellular and organismal outcomes.

## Clinical Significance
FOXR2 is implicated in various cancers due to its role as an oncogene. It is overexpressed in a range of cancer types, including breast, lung, liver, and brain cancers, and is associated with tumor proliferation and poor prognosis (Gharbaran2023Insights; Li2016FOXR2). In medulloblastoma, a pediatric brain tumor, FOXR2 is frequently mutated and overexpressed, particularly in the SHH subgroup, where it cooperates with other genes to enhance Gli1 activity, a key component of the SHH signaling pathway (Koso2014Identification). 

FOXR2's oncogenic effects are partly due to its interaction with MYC proteins, stabilizing them and activating ETS transcription circuits, which are crucial for cancer cell proliferation and transformation (Tsai2022FOXR2). In pediatric high-grade gliomas, FOXR2 expression can be driven by structural variants or somatic mutations, leading to aberrant activation of the MYC proto-oncogene and ETS transcriptional circuits (Gharbaran2023Insights). 

The gene's expression is often regulated epigenetically, with hypomethylation of its promoter region being a common mechanism for its activation in cancers (Tsai2022FOXR2). FOXR2's role in cancer makes it a potential target for therapeutic interventions, as targeting its interactions, particularly with MYC, might offer treatment benefits with fewer side effects (Li2016FOXR2).

## Interactions
FOXR2 is known to interact with the MYC and MAX proteins, forming a stable complex that plays a significant role in tumorigenesis. This interaction was identified through tandem affinity purification followed by mass spectrometry (TAP-MS) and confirmed by immunoprecipitation (IP)-western blotting experiments in MDA-MB-468 cells. FOXR2 primarily associates with MYC and MAX in chromatin fractions, indicating a chromatin-associated complex (Li2016FOXR2).

The interaction between FOXR2 and MYC is specific, as MYC binds only to FOXR1 and FOXR2, but not to other FOX transcription factors. The binding region of FOXR2 to MYC is mapped to the mid-region (residues 120-240) of MYC, while the N-terminal region of FOXR2 is required for its binding to MYC (Li2016FOXR2). FOXR2 enhances MYC's transcriptional activities, which are crucial for oncogenic transformation, and this interaction is essential for promoting cancer cell proliferation (Li2016FOXR2).

FOXR2 also binds to the promoter regions of several MYC target genes, such as CCNA1, CCND1, XRCC4, XRCC6, p15, and COL1A1, modulating their expression and contributing to oncogenic processes (Li2016FOXR2).


## References


[1. (Koso2014Identification) Hideto Koso, Asano Tsuhako, Eli Lyons, Jerrold M. Ward, Alistair G. Rust, David J. Adams, Nancy A. Jenkins, Neal G. Copeland, and Sumiko Watanabe. Identification of foxr2 as an oncogene in medulloblastoma. Cancer Research, 74(8):2351–2361, April 2014. URL: http://dx.doi.org/10.1158/0008-5472.can-13-1523, doi:10.1158/0008-5472.can-13-1523. This article has 38 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-13-1523)

[2. (Gharbaran2023Insights) Rajendra Gharbaran. Insights into the molecular roles of foxr2 in the pathology of primary pediatric brain tumors. Critical Reviews in Oncology/Hematology, 192:104188, December 2023. URL: http://dx.doi.org/10.1016/j.critrevonc.2023.104188, doi:10.1016/j.critrevonc.2023.104188. This article has 0 citations.](https://doi.org/10.1016/j.critrevonc.2023.104188)

[3. (Tsai2022FOXR2) Jessica W. Tsai, Paloma Cejas, Dayle K. Wang, Smruti Patel, David W. Wu, Phonepasong Arounleut, Xin Wei, Ningxuan Zhou, Sudeepa Syamala, Frank P.B. Dubois, Alexander Crane, Kristine Pelton, Jayne Vogelzang, Cecilia Sousa, Audrey Baguette, Xiaolong Chen, Alexandra L. Condurat, Sarah E. Dixon-Clarke, Kevin N. Zhou, Sophie D. Lu, Elizabeth M. Gonzalez, Madison S. Chacon, Jeromy J. Digiacomo, Rushil Kumbhani, Dana Novikov, J’Ya Hunter, Maria Tsoli, David S. Ziegler, Uta Dirksen, Natalie Jager, Gnana Prakash Balasubramanian, Christof M. Kramm, Michaela Nathrath, Stefan Bielack, Suzanne J. Baker, Jinghui Zhang, James M. McFarland, Gad Getz, François Aguet, Nada Jabado, Olaf Witt, Stefan M. Pfister, Keith L. Ligon, Volker Hovestadt, Claudia L. Kleinman, Henry Long, David T.W. Jones, Pratiti Bandopadhayay, and Timothy N. Phoenix. Foxr2 is an epigenetically regulated pan-cancer oncogene that activates ets transcriptional circuits. Cancer Research, 82(17):2980–3001, July 2022. URL: http://dx.doi.org/10.1158/0008-5472.can-22-0671, doi:10.1158/0008-5472.can-22-0671. This article has 8 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-22-0671)

[4. (Li2016FOXR2) Xu Li, Wenqi Wang, Yuanxin Xi, Min Gao, MyKim Tran, Kathryn E. Aziz, Jun Qin, Wei Li, and Junjie Chen. Foxr2 interacts with myc to promote its transcriptional activities and tumorigenesis. Cell Reports, 16(2):487–497, July 2016. URL: http://dx.doi.org/10.1016/j.celrep.2016.06.004, doi:10.1016/j.celrep.2016.06.004. This article has 30 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2016.06.004)